Your browser doesn't support javascript.
loading
Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib.
Zhu, You-Cai; Wan, Bing; Wu, Li-Xin; Li, Xing-Liang; Wang, Wen-Xian; Xu, Chun-Wei; Zhuang, Wu; Wei, Jian-Guo; Du, Kai-Qi.
Affiliation
  • Zhu YC; Department of Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
  • Wan B; Department of Respiratory and Critical Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 210002, China.
  • Wu LX; Department of Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
  • Li XL; Department of Tumor Molecular Laboratory, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
  • Wang WX; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou 310022, China.
  • Xu CW; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Zhuang W; Department of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
  • Wei JG; Department of Pathology, Shaoxing People's Hospital, Shaoxing 312000, China.
  • Du KQ; Department of Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
Transl Cancer Res ; 8(4): 1630-1634, 2019 Aug.
Article in En | MEDLINE | ID: mdl-35116907
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Cancer Res Year: 2019 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Cancer Res Year: 2019 Document type: Article Affiliation country: China Country of publication: China